These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 22875853)
1. Transcriptional network analysis identifies BACH1 as a master regulator of breast cancer bone metastasis. Liang Y; Wu H; Lei R; Chong RA; Wei Y; Lu X; Tagkopoulos I; Kung SY; Yang Q; Hu G; Kang Y J Biol Chem; 2012 Sep; 287(40):33533-44. PubMed ID: 22875853 [TBL] [Abstract][Full Text] [Related]
2. Silencing of bach1 gene by small interfering RNA-mediation regulates invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor in MDA-MB-468 breast cancer cells. Mohammadzadeh R; Saeid Harouyan M; Ale Taha SM Tumour Biol; 2017 Mar; 39(3):1010428317695925. PubMed ID: 28349828 [TBL] [Abstract][Full Text] [Related]
3. BACH1, the master regulator gene: A novel candidate target for cancer therapy. Davudian S; Mansoori B; Shajari N; Mohammadi A; Baradaran B Gene; 2016 Aug; 588(1):30-7. PubMed ID: 27108804 [TBL] [Abstract][Full Text] [Related]
4. BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes. Davudian S; Shajari N; Kazemi T; Mansoori B; Salehi S; Mohammadi A; Shanehbandi D; Shahgoli VK; Asadi M; Baradaran B Biomed Pharmacother; 2016 Dec; 84():191-198. PubMed ID: 27657827 [TBL] [Abstract][Full Text] [Related]
5. Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions. Lee J; Lee J; Farquhar KS; Yun J; Frankenberger CA; Bevilacqua E; Yeung K; Kim EJ; Balázsi G; Rosner MR Proc Natl Acad Sci U S A; 2014 Jan; 111(3):E364-73. PubMed ID: 24395801 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line. Aletaha M; Mansoori B; Mohammadi A; Fazeli M; Baradaran B Biomed Pharmacother; 2017 Apr; 88():34-42. PubMed ID: 28092843 [TBL] [Abstract][Full Text] [Related]
7. Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression. Shajari N; Davudian S; Kazemi T; Mansoori B; Salehi S; Khaze Shahgoli V; Shanehbandi D; Mohammadi A; Duijf PHG; Baradaran B Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1495-1504. PubMed ID: 28889753 [TBL] [Abstract][Full Text] [Related]
8. BACH1 Ser919Pro variant and breast cancer risk. Vahteristo P; Yliannala K; Tamminen A; Eerola H; Blomqvist C; Nevanlinna H BMC Cancer; 2006 Jan; 6():19. PubMed ID: 16430786 [TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852 [TBL] [Abstract][Full Text] [Related]
10. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis. Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125 [TBL] [Abstract][Full Text] [Related]
11. A prognostic gene signature for metastasis-free survival of triple negative breast cancer patients. Lee U; Frankenberger C; Yun J; Bevilacqua E; Caldas C; Chin SF; Rueda OM; Reinitz J; Rosner MR PLoS One; 2013; 8(12):e82125. PubMed ID: 24349199 [TBL] [Abstract][Full Text] [Related]
12. miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes. Croset M; Pantano F; Kan CWS; Bonnelye E; Descotes F; Alix-Panabières C; Lecellier CH; Bachelier R; Allioli N; Hong SS; Bartkowiak K; Pantel K; Clézardin P Cancer Res; 2018 Sep; 78(18):5259-5273. PubMed ID: 30042152 [TBL] [Abstract][Full Text] [Related]
13. BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition. Sato M; Matsumoto M; Saiki Y; Alam M; Nishizawa H; Rokugo M; Brydun A; Yamada S; Kaneko MK; Funayama R; Ito M; Kato Y; Nakayama K; Unno M; Igarashi K Cancer Res; 2020 Mar; 80(6):1279-1292. PubMed ID: 31919242 [TBL] [Abstract][Full Text] [Related]
14. BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition. Han W; Zhang Y; Niu C; Guo J; Li J; Wei X; Jia M; Zhi X; Yao L; Meng D Cancer Lett; 2019 Mar; 445():45-56. PubMed ID: 30654010 [TBL] [Abstract][Full Text] [Related]
15. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Lu X; Wang Q; Hu G; Van Poznak C; Fleisher M; Reiss M; Massagué J; Kang Y Genes Dev; 2009 Aug; 23(16):1882-94. PubMed ID: 19608765 [TBL] [Abstract][Full Text] [Related]
16. The HIF target MAFF promotes tumor invasion and metastasis through IL11 and STAT3 signaling. Moon EJ; Mello SS; Li CG; Chi JT; Thakkar K; Kirkland JG; Lagory EL; Lee IJ; Diep AN; Miao Y; Rafat M; Vilalta M; Castellini L; Krieg AJ; Graves EE; Attardi LD; Giaccia AJ Nat Commun; 2021 Jul; 12(1):4308. PubMed ID: 34262028 [TBL] [Abstract][Full Text] [Related]
17. An unexpected role for the ketogenic diet in triggering tumor metastasis by modulating BACH1-mediated transcription. Su Z; Liu Y; Xia Z; Rustgi AK; Gu W Sci Adv; 2024 Jun; 10(23):eadm9481. PubMed ID: 38838145 [TBL] [Abstract][Full Text] [Related]
18. A Novel Therapeutic Target, BACH1, Regulates Cancer Metabolism. Padilla J; Lee J Cells; 2021 Mar; 10(3):. PubMed ID: 33809182 [TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families. Guénard F; Labrie Y; Ouellette G; Joly Beauparlant C; Simard J; ; Durocher F J Hum Genet; 2008; 53(7):579. PubMed ID: 18414782 [TBL] [Abstract][Full Text] [Related]
20. Bach1-mediated suppression of p53 is inhibited by p19(ARF) independently of MDM2. Nishizawa H; Ota K; Dohi Y; Ikura T; Igarashi K Cancer Sci; 2012 May; 103(5):897-903. PubMed ID: 22348305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]